RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of PCRX
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Pacira Pharmaceuticals stock upgraded to Sell Candidate.
(Updated on Jul 22, 2024)

Sell candidate since Jun 27, 2024 Loss -27.59% PDF

The Pacira Pharmaceuticals stock price gained 4.34% on the last trading day (Monday, 22nd Jul 2024), rising from $19.37 to $20.21. During the last trading day the stock fluctuated 4.23% from a day low at $19.52 to a day high of $20.35. The price has fallen in 6 of the last 10 days and is down by -1.89% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 66 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $22.41 million.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $19.25 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -21.55% during the next 3 months and, with a 90% probability hold a price between $15.10 and $20.63 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

PCRX Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, July 19, 2024, and so far it has risen 4.34%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Pacira Pharmaceuticals stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $20.75 and $25.69. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Pacira Pharmaceuticals stock

Pacira Pharmaceuticals finds support from accumulated volume at $19.37 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.83 between high and low, or 4.23%. For the last week, the stock has had daily average volatility of 5.68%.

Pacira Pharmaceuticals is oversold on RSI14 (20). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PCRX) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect Pacira Pharmaceuticals to open at $20.03, and during the day (based on 14 day Average True Range), to move between $18.92 and $21.50, which gives a possible trading interval of +/-$1.29 (+/-6.38%) up or down from last closing price. If Pacira Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 12.77% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $20.22 (0.05%) than the support at $19.37 (4.16%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Pacira Pharmaceuticals stock A Buy?

Pacira Pharmaceuticals holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -4.117 Sell Candidate Upgraded

Predicted Opening Price for Pacira Pharmaceuticals of Tuesday, July 23, 2024

Fair opening price July 23, 2024 Current price
$20.03 ( 0.90%) $20.21

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for PCRX

Fibonacci Support & Resistance Levels

Level Price
R3 20.85 3.18%
R2 20.54 1.62%
R1 20.34 0.661%
Price 20.21
S1 19.71 -2.46%
S2 19.52 -3.42%
S3 19.20 -4.98%

Accumulated Volume Support & Resistance Levels

Level Price
R3 22.74 12.52%
R2 21.30 5.39%
R1 20.22 0.0495%
Price 20.21
S1 19.37 -4.16%
S2 0 -
S3 0 -

FAQ

What is the symbol for Pacira Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Pacira Pharmaceuticals is PCRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Pacira Pharmaceuticals Stock?
Pacira Pharmaceuticals holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

How to buy Pacira Pharmaceuticals Stock?
Pacira Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Pacira Pharmaceuticals Stock.

What's the current price of Pacira Pharmaceuticals Stock?
As of the end of day on the Jul 22, 2024, the price of an Pacira Pharmaceuticals (PCRX) share was $20.21.

What is the 52-week high and low for Pacira Pharmaceuticals Stock?
The 52-week high for Pacira Pharmaceuticals Stock is $40.16 and the 52-week low is $19.34.

What is the market capitalization of Pacira Pharmaceuticals Stock?
As of the Jul 22, 2024, the market capitalization of Pacira Pharmaceuticals is 940.697M.

When is the next earnings date for Pacira Pharmaceuticals?
The upcoming earnings date for Pacira Pharmaceuticals is Aug 07, 2024.
Click to get the best stock tips daily for free!

About Pacira Pharmaceuticals

Pacira Pharmaceuticals Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted ner... PCRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT